Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir Once vs Twice Daily in Type 1 Diabetes
NCT00117780Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2005
- Primary completion
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Jun 2005; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00117780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117780.